Universal Biosensors Inc Shs Chess Depository Interests US Prohibited repr UBI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.17
- Day Range
- A$0.15–0.17
- 52-Week Range
- A$0.13–0.30
- Bid/Ask
- A$0.16 / A$0.16
- Market Cap
- A$34.71 Mil
- Volume/Avg
- 9.6 Mil / 884,816
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.09%
Company Profile
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 80
Valuation
|
Metric
|
UBI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.63 |
Price/Sales | 4.80 |
Price/Cash Flow | — |
Price/Earnings
UBI
Financial Strength
|
Metric
|
UBI
|
|---|---|
Quick Ratio | 2.71 |
Current Ratio | 3.70 |
Interest Coverage | −365.72 |
Quick Ratio
UBI
Profitability
|
Metric
|
UBI
|
|---|---|
Return on Assets (Normalized) | −17.26% |
Return on Equity (Normalized) | −28.87% |
Return on Invested Capital (Normalized) | −26.30% |
Return on Assets
UBI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Zcjqrbkw | Wbbzbfh | $185.4 Bil | |
SYK
| Stryker Corp | Hcyqvlfms | Dbxsn | $127.7 Bil | |
BSX
| Boston Scientific Corp | Bmwnyzxt | Ymwvrp | $107.6 Bil | |
MDT
| Medtronic PLC | Nntpbcxwv | Zphnr | $105.9 Bil | |
DXCM
| DexCom Inc | Fzndqvwrp | Qsq | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Njsclqyg | Jdflzxq | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pffxjvbg | Jlvc | $24.6 Bil | |
ALGN
| Align Technology Inc | Pvhnkytkg | Fymcms | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Zzjxyngpx | Tdfpyg | $18.7 Bil | |
PODD
| Insulet Corp | Rkdmhgbmp | Ytncbg | $11.6 Bil |